HIV Raises Hepatitis C Liver Disease Risk in Women More Than Men - Cancer Health
HIV Raises Hepatitis C Liver Disease Risk in Women More Than Men Cancer Health
Liver Cancer News
FDA-approved drug may finally help immunotherapy defeat rare liver cancer - ScienceDaily
FDA-approved drug may finally help immunotherapy defeat rare liver cancer ScienceDaily
UNC Lineberger Researchers Advance Early-Stage Liver Cancer Detection and Treatments - UNC Health
UNC Lineberger Researchers Advance Early-Stage Liver Cancer Detection and Treatments UNC Health
Mayo Clinic study finds common drug may help prevent life-threatening liver failure after surgery - Florida Hospital News and Healthcare Report
Mayo Clinic study finds common drug may help prevent life-threatening liver failure after surgery Florida Hospital News and Healthcare Report
Rare combined liver cancer highlights challenges in diagnosis and treatment - EurekAlert!
Rare combined liver cancer highlights challenges in diagnosis and treatment EurekAlert!
New blood score may help identify patients most at risk of liver failure, liver cancer or death - VCU Health
New blood score may help identify patients most at risk of liver failure, liver cancer or death VCU Health
Nano-enabled spatially selective protein degradation modulates lactate metabolism to potentiate antitumor immunity in liver cancer - Nature
Nano-enabled spatially selective protein degradation modulates lactate metabolism to potentiate antitumor immunity in liver cancer Nature
Study Warns on Sugary Drinks and Liver Cancer - MedPage Today
Study Warns on Sugary Drinks and Liver Cancer MedPage Today
Missouri hospital treats liver cancer with bubbles, sound waves that ‘liquefy’ tumors - American Hospital Association
Missouri hospital treats liver cancer with bubbles, sound waves that ‘liquefy’ tumors American Hospital Association
USF Health secures new funding to advance research on promising liver cancer drug - University of South Florida
USF Health secures new funding to advance research on promising liver cancer drug University of South Florida
Sequential Logic-Gated Prioritization of microRNA Networks Identifies DKK1 as a Candidate Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease-Hepatocellular Carcinoma (MASLD-HCC) and Metastasis - Cureus
Sequential Logic-Gated Prioritization of microRNA Networks Identifies DKK1 as a Candidate Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease-Hepatocellular Carcinoma (MASLD-HCC) and Metastasis Cureus
Fat-associated liver disease plays a key role in the development of liver cancer - Hospital Clínic Barcelona
Fat-associated liver disease plays a key role in the development of liver cancer Hospital Clínic Barcelona
What to Know About Liver Cancer: Causes, Symptoms and Treatments - AARP
What to Know About Liver Cancer: Causes, Symptoms and Treatments AARP
A new mouse model of virus-driven liver cancer may open the door to better diagnosis and treatments - The Rockefeller University
A new mouse model of virus-driven liver cancer may open the door to better diagnosis and treatments The Rockefeller University
Liver Cancer Progression Slowed by Adding Immunotherapy to TACE - Memorial Sloan Kettering Cancer Center
Liver Cancer Progression Slowed by Adding Immunotherapy to TACE Memorial Sloan Kettering Cancer Center
Liver cancer deaths are rapidly increasing – tackling preventable causes would save lives - The Conversation
Liver cancer deaths are rapidly increasing – tackling preventable causes would save lives The Conversation
Study reveals how a rare pediatric liver cancer emerges and its response to therapy - Baylor College of Medicine Blog Network -
Study reveals how a rare pediatric liver cancer emerges and its response to therapy Baylor College of Medicine Blog Network -
How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients - Rutgers University
How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients Rutgers University
Immunotherapy Combo Delays Progression of Inoperable Liver Cancer - Cancer Health
Immunotherapy Combo Delays Progression of Inoperable Liver Cancer Cancer Health
Fred Hutch investigates an illuminating liver cancer risk - American Hospital Association
Fred Hutch investigates an illuminating liver cancer risk American Hospital Association
Mount Sinai Researchers Publish Landmark Cell Review Defining the “Hallmarks of Liver Cancer” - Mount Sinai
Mount Sinai Researchers Publish Landmark Cell Review Defining the “Hallmarks of Liver Cancer” Mount Sinai
Tumor cell villages define the co-dependency of tumor and microenvironment in liver cancer - Nature
Tumor cell villages define the co-dependency of tumor and microenvironment in liver cancer Nature
EMERALD-3 Trial: STRIDE Regimen Improves PFS in Liver Cancer - Oncology News Central
EMERALD-3 Trial: STRIDE Regimen Improves PFS in Liver Cancer Oncology News Central
Y90-radioembolization radiation therapy for liver cancer patients - UT MD Anderson
Y90-radioembolization radiation therapy for liver cancer patients UT MD Anderson
A Novel CD147-Targeting Nanobody for Immuno-PET Imaging of Liver Cancer - Journal of Nuclear Medicine
A Novel CD147-Targeting Nanobody for Immuno-PET Imaging of Liver Cancer Journal of Nuclear Medicine
Liver cancer survivor thankful for immunotherapy clinical trial - UT MD Anderson
Liver cancer survivor thankful for immunotherapy clinical trial UT MD Anderson
Are Artificially Sweetened Beverages Linked to Liver Cancer? - Medscape
Are Artificially Sweetened Beverages Linked to Liver Cancer? Medscape
FedLiverNet: a federated learning framework for privacy-preserving and efficient liver cancer detection - Nature
FedLiverNet: a federated learning framework for privacy-preserving and efficient liver cancer detection Nature
Quality of Life, Nutrition Linked to Survival in Advanced Liver Cancer - Cure Today
Quality of Life, Nutrition Linked to Survival in Advanced Liver Cancer Cure Today
Living out loud after complex liver cancer treatment - Mayo Clinic News Network
Living out loud after complex liver cancer treatment Mayo Clinic News Network
MLKL in liver parenchymal cells promotes liver cancer in murine metabolic dysfunction-associated steatotic liver disease - Nature
MLKL in liver parenchymal cells promotes liver cancer in murine metabolic dysfunction-associated steatotic liver disease Nature
PLT012 Receives FDA Fast Track Designation for Liver Cancer Treatment - Cure Today
PLT012 Receives FDA Fast Track Designation for Liver Cancer Treatment Cure Today
Tributes to North Wales girl, 10, who battled cancer but ‘never stopped smiling’ - Wrexham and Flintshire News, Sport, Events | The Leader
Tributes to North Wales girl, 10, who battled cancer but ‘never stopped smiling’ Wrexham and Flintshire News, Sport, Events | The Leader
American Liver Foundation Hosted Liver Cancer Briefing on Capitol Hill - American Liver Foundation
American Liver Foundation Hosted Liver Cancer Briefing on Capitol Hill American Liver Foundation
Live Procedure - Histotripsy: A Noninvasive Ablation Procedure for Liver Cancer - Roswell Park Comprehensive Cancer Center
Live Procedure - Histotripsy: A Noninvasive Ablation Procedure for Liver Cancer Roswell Park Comprehensive Cancer Center
Elevated TMEM45B expression promotes liver cancer progression and is associated with MET signaling activation - Nature
Elevated TMEM45B expression promotes liver cancer progression and is associated with MET signaling activation Nature
Five Things You May Not Know About Liver Cancer—from Managing Risks to Treating Disease - NYU Langone Health
Five Things You May Not Know About Liver Cancer—from Managing Risks to Treating Disease NYU Langone Health
Dr. Richard Finn recognized for advancing liver cancer treatments - UCLA Health
Dr. Richard Finn recognized for advancing liver cancer treatments UCLA Health
SNORA49 negatively regulates self-renewal of liver cancer stem cells and hepatocarcinogenesis via suppressing SOX9 transcription - Nature
SNORA49 negatively regulates self-renewal of liver cancer stem cells and hepatocarcinogenesis via suppressing SOX9 transcription Nature
UCLA researchers awarded $3.2 million NIH grant to develop AI tool for more personalized liver cancer treatment - UCLA Health
UCLA researchers awarded $3.2 million NIH grant to develop AI tool for more personalized liver cancer treatment UCLA Health